Records 1 - 4
| Differences in Genomic Alterations Between Brain Metastases and Primary Tumors.
Neurosurgery 2020 Dec .
Dono Antonio, Takayasu Takeshi, Yan Yuanqing, Bundrant Bethany E, Arevalo Octavio, Lopez-Garcia Carlos A, Esquenazi Yoshua, Ballester Leomar
| Expression level of CRKL and AXL combined with exon 19 deletion in EGFR and ALK status confer differential prognosis of lung adenocarcinoma subtypes.
Oncology letters 2016 Nov 12 (5): 3312-3322.
Cai Yi-Ran, Dong Yu-Jie, Wu Hong-Bo, Yu Da-Ping, Zhou Li-Juan, Su Dan, Zhang Li, Chen Xue-Ji
| A window of opportunity study of potential tumor and soluble biomarkers of response to preoperative erlotinib in early stage non-small cell lung cancer.
Oncotarget 2016 May 7 (18): 25632-9.
Sacher Adrian G, Le Lisa W, Lara-Guerra Humberto, Waddell Thomas K, Sakashita Shingo, Chen Zhuo, Kim Lucia, Zhang Tong, Kamel-Reid Suzanne, Salvarrey Alexandra, Darling Gail, Yasufuku Kazuhiro, Keshavjee Shaf, de Perrot Marc, Shepherd Frances A, Liu Geoffrey, Tsao Ming Sound, Leighl Natasha
| Differential expression of CRKL and AXL genes in lung adenocarcinoma subtypes according to the epidermal growth factor receptor and anaplastic lymphoma kinase gene status.
Biomedical reports 2014 Jul 2 (4): 481-489.
Yu DA-Ping, Dong Yu-Jie, Zhang Hai-Qing, Wang Jing-Hui, Qu Yang, Zhou Li-Juan, Su Dan, Zhang Li-Li, Zhao Dan, Cai Yi-R